Key result
Both FAC and AC protocols resulted in similar complete blood count changes after 4 cycles of chemotherapy in breast cancer patients, including mild decreases in hemoglobin and significant decreases in RBCs.
Why the study?
Does the FAC protocol compared to the AC protocol cause different CBC changes in female breast cancer patients?
Observational (n=150)
No
Does the FAC protocol compared to the AC protocol cause different CBC changes in female breast cancer patients?
Answers are grounded in this paper and cite their sources.
Both FAC and AC chemotherapy protocols in breast cancer patients lead to mild anemia (decreased Hb and RBCs) but do not significantly differ in their overall impact on complete blood count parameters over 4 cycles.
Objective: FAC (5 fluorouracil, Adriamycin and cyclophosphamide) and AC (Adriamycin and cyclophosphamide) protocols have significant anti-tumor activity in patients with breast cancer. Our objective was to evaluate the CBC changes in patients undergoing FAC and AC protocols.
No takes yet. Share an insight, caveat, or question.
Zikria Saleem (2017) conducted an observational in Breast cancer (n=150). FAC (5-Flourouracil, Adriamycin, Cyclophosphamide) protocol vs. AC (Adriamycin, Cyclophosphamide) protocol was evaluated on Complete blood count (CBC) changes. Both FAC and AC protocols resulted in similar complete blood count changes after 4 cycles of chemotherapy in breast cancer patients, including mild decreases in hemoglobin and significant decreases in RBCs.
Synapse has enriched 10 related papers. Consider them for comparative context: